Forbes February 6, 2020
M&A has been confined to smaller deals in Medicaid- and Medicare-focused companies.
By Dane Hamilton and Claire Rychlewski
The U.S. health insurance market, roiled by transformative deals in recent years, will likely face a lull in major deal activity in 2020 while firms await critical federal election outcomes, industry executives said.
Looking to diversify, gain scale and efficiencies, pharmacy giant CVS Health in late 2018 closed a $70 billion acquisition of health insurance major Aetna. Cigna followed shortly with the $54 billion purchase of pharmacy benefits major Express Scripts.
The moves fueled speculation that other buyers like Walgreens Boots Alliance or Walmart would look to emulate CVS’s strategy and buy a health insurer like Humana, or that insurer Anthem could...
Today's Sponsors
Today's Sponsor